1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Medical - Devices
SANUWAVE Health Inc.

SANUWAVE Health Inc.

SNWV
SANUWAVE Health Inc.US flagNASDAQ
4.38
USD
-0.07
- -
37.66MMarket Cap
SANUWAVE Health Inc.
SNWV
(NASDAQ)

Recent

price

4.38

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
21.14
15.34
13.79
10.66
6.59
5.74
4.79
1.99
4.64
1.89
4.02
9.41
11.43
9.64
7.31
5.14
5.11
Revenue per Share
-432.96
-195.66
-114.77
-150.62
-46.47
-28.62
-22.44
-14.96
-29.17
-19.21
-30.68
-19.72
-7.02
-12.19
-7.41
1.38
1.67
Basic EPS, GAAP
-170.23
-169.58
-76.95
-52.31
-52.01
-20.67
-11.18
-4.13
-9.19
-11.91
-12.67
-5.02
-11.72
-2.14
0.44
0.23
0.47
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
-266.56
-27.56
-116.37
-60.5
-9.58
-34.96
-18.89
-26.6
-36.99
-12.85
-10.93
-30.33
-28.03
-14.2
-1.85
0.19
0.32
Book Value per Share
-313.21
-55.07
-138.27
-69.58
-13.37
-36.78
-18.89
-26.6
-36.99
-12.85
-21.93
-40.53
-36.5
-18.04
-3.14
-1.01
-0.86
Tangible Book Value per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
1
1
1
1
2
4
9
9
Basic Weighted Avg Shares
1
1
1
1
1
1
1
1
2
1
4
13
17
20
33
44
44
Sales/Revenue/Turnover
-1,597.64
-1,097.61
-788.12
-746.97
-703.77
-469.99
-241.13
-517.85
-388.11
-854.87
-444.05
-108.7
-53.47
-2.65
11.79
11.23
1.54
Operating Margin (%)
1
- -
- -
- -
- -
- -
- -
- -
- -
- -
1
1
1
1
1
1
1
Depreciation Expense
-15
-10
-6
-11
-6
-5
-6
-6
-12
-10
-31
-27
-10
-26
-33
12
14
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
0.72
0.04
Effective Tax Rate (%)
-2,048.53
-1,275.75
-832.21
-1,412.41
-705.02
-498.22
-467.93
-749.86
-628.7
-1,013.86
-762.56
-209.52
-61.48
-126.52
-101.38
26.82
32.6
Profit Margin (%)
-7
2
-2
-2
-2
-1
-7
-10
-15
-10
-28
-52
-54
-55
-27
7
5
Working Capital
- -
- -
- -
5
- -
5
- -
- -
- -
- -
1
1
- -
- -
- -
17
15
LT Debt
-11
-2
-7
-6
-2
-6
-7
-10
-15
-10
-14
-39
-41
-43
-16
2
3
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
24.44
3.61
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
104.15
97.59
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
6
6
6
LT Borrowings
16
15
14
LT Finance Leases
1
1
2
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
9
9
9
Market Capitalization
256
149
86

Working Capital

FRC

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
25
24
23
Cash, Cash Equivalents & STI
12
11
9
Accounts Receivable, Net
5
6
6
Inventories
6
6
7
Total Current Liabilities
18
18
18
Payables & Accruals
10
11
11
ST Debt
6
6
6
Deferred Revenue
- -
- -
1

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
13.87%
4.18%
-110.25%
Free Cash Flow
13.7%
-23.33%
-1.58%
Net Income, GAAP
28.53%
-6.19%
-135.71%
Sales/Revenue/Turnover
76.29%
73.24%
34.98%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
6
7
9
10
33
2025
9
10
11
13
44
2026
10
10
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-1.46
2.08
-6.48
-1.49
-7.41
2025
-0.72
0.06
1.2
- -
1.38
2026
-0.17
-0.08
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Similar Companies
Outset Medical, Inc. (OM)
Allgens Medical Technology Co. Ltd. (688613.SS)
InnoCare Optoelectronics Corporation (6861.TW)
NAYA Biosciences, Inc. (NAYA)
Demant A/S (WILYY)
Micro-X Limited (MX1.AX)
Business
SANUWAVE Health, Inc. (SNWV) develops and commercializes noninvasive medical devices utilizing shockwave and ultrasound technologies to promote regenerative healing in skin, musculoskeletal, and vascular tissues. The company offers the UltraMIST system, which delivers low-frequency, non-contact ultrasound energy through a saline mist for treating acute and chronic wounds including diabetic foot ulcers, pressure ulcers, and burns; the dermaPACE system, employing Pulsed Acoustic Cellular Expression (PACE) technology for first-line treatment of diabetic wounds and pressure ulcers; and the orthoPACE system, designed for orthopedic, trauma, and sports injury applications such as bone healing and chronic tendonitis. SANUWAVE operates in the United States and internationally, with a focus on wound care, orthopedics, and regenerative medicine markets served by hospitals, clinics, and government facilities including the VA and military bases; it was founded in 2004 and is headquartered in Eden Prairie, Minnesota. In February 2024, the company entered a strategic partnership with Premier Shockwave to distribute dermaPACE into VA, Indian Health Services, and military base markets; it announced Q3 FY2025 financial results in late 2025, reflecting ongoing production ramp-up for UltraMIST systems and anticipation of expanded manufacturing capacity into 2026; a previously proposed merger with SEP Acquisition Corp. was terminated in June 2024.

Company News

Company News APIChatGPT

  • seekingalpha.com

    SANUWAVE Health, Inc. (SNWV) Q2 2026 Earnings Call Transcript

  • marketbeat.com

    Sanuwave Health Q2 Earnings Call Highlights

  • globenewswire.com

    Sanuwave Announces Q2 FY2026 Financial Results

  • globenewswire.com

    Sanuwave Will Host a Conference Call on August 7, 2026 at 8:30 AM (ET) to Present Q2 2026 Financial Results

  • globenewswire.com

    Sanuwave Health Reports Preliminary Q2 2026 Revenue of $9.6–$9.8 Million, Above High End of Revised Guidance

  • globenewswire.com

    Sanuwave Health Updates Second Quarter 2026 Guidance

  • marketbeat.com

    Sanuwave Health Q1 Earnings Call Highlights

  • seekingalpha.com

    SANUWAVE Health, Inc. (SNWV) Q1 2026 Earnings Call Transcript

  • zacks.com

    Sanuwave Health Inc. (SNWV) Reports Q1 Loss, Beats Revenue Estimates

  • globenewswire.com

    Sanuwave Announces Revenues and Financial Results for Q1 FY2026

  • globenewswire.com

    Sanuwave Will Host a Conference Call on May 13, 2026 at 8:30 AM (ET) to Present Q1 2026 Financial Results

  • globenewswire.com

    Sanuwave Will Host a Conference Call on May 13, 2026 at 8:30 AM (ET) to Present Q1 2026 Financial Results

  • zacks.com

    Sanuwave Health Inc. (SNWV) May Report Negative Earnings: Know the Trend Ahead of Q1 Release

  • defenseworld.net

    Ayr Wellness (OTCMKTS:AYRWF) and Sanuwave Health (NASDAQ:SNWV) Financial Analysis

  • gurufocus.com

    SANUWAVE Health Inc (SNWV) Shares Fall 7.2% -- GF Value Says Still Overvalued

  • defenseworld.net

    Head to Head Survey: Sanuwave Health (NASDAQ:SNWV) and INLIF (NASDAQ:INLF)

  • seekingalpha.com

    SANUWAVE Health, Inc. (SNWV) Q4 2025 Earnings Call Transcript

  • globenewswire.com

    Sanuwave Announces Record Revenues and Financial Results for Q4 and Full Year 2025

  • globenewswire.com

    Sanuwave Will Host a Conference Call on March 27, 2026 at 8:30 AM (ET) to Present Q4 and Full Year 2025 Financial Results

  • defenseworld.net

    SANUWAVE Health (OTCMKTS:SNWV) and Arch Therapeutics (OTCMKTS:ARTH) Critical Review